Michael D. Dale, Chief Executive Officer at ATS MEDICAL INC (ATSI), sold 25,000 shares at $3.00 ($75K) on 2008-08-10, disclosed to the SEC on 2009-08-10.
Scheduled sale ($75k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ABT | SELL | 2023-03-02 | $243K | — | Filing → |
| ABT | SELL | 2022-03-10 | $468K | — | Filing → |
| ABT | SELL | 2022-03-02 | $249K | — | Filing → |